Aperam Shares Jump 4.9% Mid-Session Despite Deteriorating Ebitda Outlook

Aperam's stock price has risen 4.9% by midday this Wednesday, January 7, 2026, reaching 35.98 euros from 34.30 euros the previous day. The trading volume accounts for 0.17% of the capital, indicating sustained activity. This increase follows the announcement on January 6 of an expected adjusted Ebitda below 74 million euros for the fourth quarter of 2025. The company cites weaker seasonal demand in Brazil and challenging conditions in Europe, where the order book shows no signs of recovery. Despite these cautious outlooks, the market appears to appreciate Aperam's continued debt reduction, with a decrease of more than 200 million euros from the first to the fourth quarter of 2025. The steelmaker specifies that cash flow generation continued thanks to working capital optimization. Over the past seven days, the stock has gained 1.35%, showing a more pronounced upward trend over three months, with a 13.36% increase. Over one year, the performance reaches 40.55%, confirming a significant rebound from the lows. The stock is trading above its 50-day (32.69 euros) and 200-day (28.71 euros) moving averages, indicating a bullish underlying trend. The monthly volatility is at 9.86%, reflecting increased sensitivity to sectoral and macroeconomic announcements.

Technically, Aperam's stock shows a Relative Strength Index (RSI) at 51, a neutral positioning that suggests a balance between buyers and sellers, with no signs of overbuying or overselling. This level allows for the continuation of the movement without immediate risk of reversal. The Bollinger Bands, with an upper boundary at 36.51 euros and a lower boundary at 32.27 euros, frame the current price of 35.98 euros. The stock is trading in the upper part of this channel, indicating sustained buying pressure without exiting the comfort zone defined by this volatility indicator. The MACD Line is at 0.78 and the Signal Line at 0.76, with a slightly positive MACD Histogram at 0.02. This setup indicates a moderate bullish momentum, without major divergence, and validates the upward trend observed over several sessions. The resistance threshold is at 37.28 euros, a level recently tested, while the technical support rests at 31.02 euros. The ATR (Average True Range) at 0.67 reflects contained volatility, facilitating a step-by-step progression. The stock also benefits from favorable price target revisions, notably from Morgan Stanley, which upgraded its recommendation to 'overweight' in mid-December with a target of 40 euros, and from JP Morgan, which raised its target to 35 euros at the beginning of December.